Drawing parallels with the use of Serpin Family H member 1 (SERPINH1) in developing an immunotherapy efficacy scoring system for osteosarcoma patients [42], the influence of SERPING1 on immunotherapy outcomes could be attributed to its role in complement system activation, pivotal in immune surveillance against malignant cells. The gene discussed is SERPINH1; the disease is osteosarcoma.